Browsing by Author Ascierto, Paolo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2012Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trialKefford, Richard (Rick); Long, Georgina; Algazi, Alain; Ascierto, Paolo; Chapman, Paul; Davies, Michael; et al, Various; Hauschild, A; Mortier, Laurent; Puzanov, Igor; Robert, C; Tawbi, Hussein; Trefzer, Uwe; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreDabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial, The Lancet Oncology, vol.13, 11, 2012,pp 1087-1095
2016Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III checkmate 066 studyLong, Georgina; Abernethy, Amy P; Ascierto, Paolo; Atkinson, V; Coon, C.; Dastani, I; Gilloteau, I; Hassel, Jessica; Robert, Caroline; Rutkowski, Piotr; Savage, Kerry; Taylor, F.; Waxman, I M; Northern Clinical School: MedicineEffect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III checkmate 066 study, Annals of Oncology, vol.27, 10, 2016,pp 1940-1946
2012FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5th–6 th 2011”Kefford, Richard (Rick); Ascierto, Paolo; Curti, Brendan; et al, Various; Faries, Mark B.; Ferrone, Soldano; Flaherty, Keith; Fox, Bernard; Gajewski, Thomas; Gershenwald, Jeffrey E.; Gogas, Helen; Grimaldi, Antonio; Western Clinical School: Westmead Millennium InstituteFUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5th–6 th 2011”, Journal of Translational Medicine, vol.10, May, 2012,pp 1-17
2014Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013Kefford, Richard (Rick); Anderson, Ana Carrizosa; Ascierto, Paolo; Bifulco, Carlo; Cochran, Alistair J.; Eggermont, Alexander; et al, Various; Faries, Mark B.; Ferrone, Soldano; Garbe, Claus; Gershenwald, Jeffrey E.; Grimaldi, Antonio; Western Clinical School: Westmead Millennium InstituteFuture perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013, Journal of Translational Medicine, vol.12, N/A, 2014,pp 1-29
2013Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic MelanomaKefford, Richard (Rick); Long, Georgina; Amaravadi, Ravi; Arya, Niki; Ascierto, Paolo; et al, Various; Grob, Jean-Jacques; Guckert, Mary; Hamid, Omid; Kim, Kevin; Lebbe, Celeste; Minor, David; O'Hagan, Anne; Ribas, Antoni; Schadendorf, D; Simeone, Ester; Wilhelm, Tabea; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentrePhase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma, Journal of Clinical Oncology, vol.31, 26, 2013,pp 3205-3211
2014Surrogate endpoints for overall survival in metastatic melanoma: A meta-analysis of randomised controlled trialsKefford, Richard (Rick); Long, Georgina; Ascierto, Paolo; Dummer, R; Eggermont, Alexander; Flaherty, Keith; Hauschild, A; Hennig, Michael; Kirkwood, John; Lee, Sandra J; Lorigan, Paul; Mackensen, Andreas; McArthur, Grant A.; O'Day, Steven; Patel, Poulam; Robert, Caroline; Schadendorf, D; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreSurrogate endpoints for overall survival in metastatic melanoma: A meta-analysis of randomised controlled trials, The Lancet Oncology, vol.15, 3, 2014,pp 297-304
2016Survival of patients with advanced metastatic melanoma: The impact of novel therapiesLong, Georgina; Ascierto, Paolo; et al, Various; Flaherty, Keith; Grob, Jean-Jacques; Hauschild, Axel; Larkin, James; Lorigan, Paul; McArthur, Grant A.; Rohmel, Joachim; Ugurel, Selma; Northern Clinical School: MedicineSurvival of patients with advanced metastatic melanoma: The impact of novel therapies, European Journal of Cancer, vol.53, N/A, 2016,pp 125-134
2017Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Long, Georgina; Ascierto, Paolo; et al, Various; Flaherty, Keith; Grob, Jean-Jacques; Hauschild, Axel; Larkin, James; Lorigan, Paul; McArthur, Grant A.; Rohmel, Joachim; Ugurel, Selma; Northern Clinical School: MedicineSurvival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017, European Journal of Cancer, vol.83, N/A, 2017,pp 247-257